Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer

Abstract Background Detecting carcinoma prostate (CaP) after intravesical Bacillus Calmette Guerin (BCG) immunotherapy for non‐muscle invasive bladder cancer (NMIBC) poses diagnostic challenges. Granulomatous prostatitis (GP) has an incidence of 0.8%–3.3% in post‐intravesical BCG patients and 6% inc...

Full description

Saved in:
Bibliographic Details
Main Authors: Arjun Pon Avudaiappan, Pushan Prabhakar, Rachel Siretskiy, Andrew Renshaw, Ahmed Eldefrawy, Murugesan Manoharan
Format: Article
Language:English
Published: Wiley 2024-11-01
Series:BJUI Compass
Subjects:
Online Access:https://doi.org/10.1002/bco2.446
Tags: Add Tag
No Tags, Be the first to tag this record!